Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nitazoxanide in Renal Impairment
NCT05368935Phase 1Completed
- Sponsor
- Genfit
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of nitazoxanide in liver failure (4 arms), sponsored by Genfit. Primary endpoints: Maximum observed plasma concentration, Area under the plasma concentration time curve from time zero to last quantifiable concentration and 1 more. Started Apr 2022; status: completed.
02
Drugs
nitazoxanide
03
Conditions
liver failure
Beyond the preview
Go deeper on NCT05368935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05368935.